Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities

[1] Scheibe A(2017)Safe treatment and treatment of safety: call for a harm-reduction approach to drug-use disorders in South Africa South African Heal Rev. 1 197-204

[2] Shelly S(2018)How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 21 1335-1374

[3] Versfeld A(2009)Diagnosis, management, and treatment of hepatitis C: an update Hepatology. 49 S80-S89

[4] Howell S(2013)Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis Clin Infect Dis. 57 S22-S26

[5] Marks M(2015)Prevention, treatment and care of hepatitis C virus infection among people who inject drugs Int J Drug Policy 26 1014-1020

[6] Hutin YJ-F(2013)Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements Clin Infect Dis. 57 2112-2116

[7] Bulterys M(2017)Elimination of HCV as a public health concern among people who inject drugs by 2030 – what will it take to get there? J Int AIDS Soc Taylor & Francis 20 1067-1075

[8] Hirnschall GO(2013)Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review Patient Prefer Adherence. 7 1-11

[9] Ghany M(2018)Empathic response and no need for perfection: reflections on harm reduction engagement in South Africa Crit Public Health. Taylor & Francis 1596 1-9

[10] Strader D(2019)HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016 Harm Reduct J. Harm Reduction Journal 16 56-61

[1] Scheibe A(2017)Safe treatment and treatment of safety: call for a harm-reduction approach to drug-use disorders in South Africa South African Heal Rev. 1 197-204

[2] Shelly S(2018)How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 21 1335-1374

[3] Versfeld A(2009)Diagnosis, management, and treatment of hepatitis C: an update Hepatology. 49 S80-S89

[4] Howell S(2013)Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis Clin Infect Dis. 57 S22-S26

[5] Marks M(2015)Prevention, treatment and care of hepatitis C virus infection among people who inject drugs Int J Drug Policy 26 1014-1020

[6] Hutin YJ-F(2013)Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements Clin Infect Dis. 57 2112-2116

[7] Bulterys M(2017)Elimination of HCV as a public health concern among people who inject drugs by 2030 – what will it take to get there? J Int AIDS Soc Taylor & Francis 20 1067-1075

[8] Hirnschall GO(2013)Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review Patient Prefer Adherence. 7 1-11

[9] Ghany M(2018)Empathic response and no need for perfection: reflections on harm reduction engagement in South Africa Crit Public Health. Taylor & Francis 1596 1-9

[10] Strader D(2019)HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016 Harm Reduct J. Harm Reduction Journal 16 56-61